
Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 1 of a 3-Part Series
Breast Cancer Update
00:00
Can I Use Cappy Vissertib in Tumors?
Cappy Vissertib was approved for oral use. Can you kind of put this in a class of agents where we've seen tolerability issues? You mentioned Cappy's Estrin, another serge involved. There's tons of trials. It seems like there's tons of agents. So I guess we'll just have to deal with it as they come out and the data comes out and they get approved.
Play episode from 49:47
Transcript


